Latest Security News

The Takeovers Panel has declined to find unacceptable circumstances in Diamond Infraco’s bid for Atlas Arteria, accepting ASIC relief and an undertaking that address concerns over the conditional price increase mechanism.

ClearVue Technologies has secured a A$305,000 contract to supply over 800m² of building-integrated photovoltaic glazing for the Rio Business Centre redevelopment in Paphos, Cyprus, marking a tangible commercial step for its solar façade technology.

Kuniko Limited’s Phase 1 drilling at the Commonwealth-Silica Hill Project delivers compelling high-grade gold, silver, and base metal results, validating extensions beyond known mineralisation and setting the stage for a larger Phase 2 program starting in July.

Island Pharmaceuticals has appointed Raymond Taylor, a former BioCryst executive with deep Galidesivir expertise and US government funding experience, to accelerate development and procurement efforts for its broad-spectrum antiviral amid rising viral threats.

Comet Ridge has revised its acquisition deal for Santos’ stake in the Mahalo Gas Project, cutting upfront cash and extending deadlines to navigate new government gas reservation policy uncertainty.

AnteoTech has secured independent validation of its Ultranode™ 95 silicon anode in commercial-format battery cells, demonstrating over 40% higher energy density and strong cycle life, advancing its push into the growing drone battery market.

West Wits Mining has locked in a ZAR 875 million senior loan facility with Absa and Nedbank, replacing earlier funding and boosting support for its Qala Shallows project; the first new South African gold mine in over 15 years.

Elanor Investors Group has obtained an ASX waiver allowing it to delay issuing stapled securities as part of its acquisition of Singapore-based Firmus Capital until July 10, 2026, due to pending regulatory approvals.

Adherium Limited plans a 1-for-100 share consolidation pending shareholder approval, aiming to reduce share count and enhance marketability.

Vection Technologies has secured approximately $1.1 million in new orders for FY26, including a $572k extension with a classified defence partner supported by Dell Technologies and $513k in Algho AI platform contracts across four enterprise sectors.

Argenica Therapeutics has passed a critical FDA genotoxicity test for its stroke drug ARG-007, advancing its IND application and edging closer to Phase 2b clinical trials in the US and Australia.

Eden Innovations appoints former European Parliament member Antanas Guoga to lead EdenShield’s push into European defence and critical infrastructure markets amid surging regional security spending.